McNaughton R J, Shucksmith J
School of Health and Care, Health and Social Care Institute, Teesside University, Middlesbrough TS1 3BA, UK Fuse (UKCRC Centre for Translational Research in Public Health), Newcastle University, Newcastle-upon-Tyne NE2 4AX, UK.
J Public Health (Oxf). 2015 Jun;37(2):218-25. doi: 10.1093/pubmed/fdu066. Epub 2014 Sep 18.
The Department of Health introduced a risk assessment, management and reduction programme, NHS Health Checks, which aimed to reduce premature morbidity and mortality from cardiovascular diseases for those aged 40-74. Those identified as at increased risk of CVD are offered prophylactic medication and lifestyle advice to reduce their risk. Health gains will only be achieved if patients are compliant with advice/intervention however. This study sought to understand factors that influenced adherence to medication and advice in 'high-risk' patients.
Qualitative data were collected through 29 semi-structured interviews with a purposive sample of individuals who had been identified as at high-risk of CVD. Participants had been offered lifestyle advice, lipid lowering medications and attended at least one annual review.
Findings explore the challenges and experiences confronting 'high-risk' individuals when making decisions about engaging with intervention. Key findings explore: statin adherence, as well as adherence to advice about diet, physical activity, alcohol consumption and smoking cessation.
Attention needs to be paid to the way prophylactic medications are prescribed and explained to high-risk patients. Consistent provision of tailored lifestyle advice and access to appropriate services could facilitate sustained changes to factors that increase CVD risk.
卫生部推出了一项风险评估、管理和降低计划,即国民健康服务健康检查,旨在降低40至74岁人群心血管疾病的过早发病和死亡率。那些被确定为心血管疾病风险增加的人会得到预防性药物治疗和生活方式建议,以降低他们的风险。然而,只有患者遵守建议/干预措施,才能实现健康收益。本研究旨在了解影响“高危”患者坚持用药和遵循建议的因素。
通过对29名被确定为心血管疾病高危人群的个体进行有目的抽样的半结构化访谈收集定性数据。参与者已获得生活方式建议、降脂药物治疗,并至少参加了一次年度复查。
研究结果探讨了“高危”个体在决定是否参与干预时面临的挑战和经历。主要研究结果探讨了:他汀类药物的依从性,以及对饮食、体育活动、饮酒和戒烟建议的依从性。
需要关注向高危患者开处方和解释预防性药物的方式。持续提供量身定制的生活方式建议并获得适当的服务,有助于持续改变增加心血管疾病风险的因素。